Addex Therapeutics Ltd. (ADXN)
3.18
+0.08
(+2.58%)
USD |
NASDAQ |
Oct 06, 16:00
2.97
-0.21
(-6.60%)
After-Hours: 20:00
Addex Therapeutics EPS Diluted (Quarterly) : -2.160 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.160 |
| March 31, 2026 | -2.211 |
| December 31, 2025 | -2.339 |
| September 30, 2025 | -2.099 |
| June 30, 2025 | -2.659 |
| March 31, 2025 | -2.000 |
| December 31, 2024 | -1.677 |
| September 30, 2024 | -2.155 |
| June 30, 2024 | 10.17 |
| March 31, 2024 | -4.344 |
| December 31, 2023 | -4.399 |
| September 30, 2023 | -4.598 |
| June 30, 2023 | -4.945 |
| March 31, 2023 | -5.097 |
| December 31, 2022 | -7.614 |
| September 30, 2022 | -10.67 |
| Date | Value |
|---|---|
| June 30, 2022 | -23.96 |
| March 31, 2022 | -19.96 |
| December 31, 2021 | -16.61 |
| September 30, 2021 | -13.78 |
| June 30, 2021 | -18.15 |
| March 31, 2021 | -10.43 |
| December 31, 2020 | -10.52 |
| September 30, 2020 | -16.19 |
| June 30, 2020 | -14.55 |
| March 31, 2020 | -20.06 |
| December 31, 2007 | -256.86 |
| June 30, 2007 | -324.59 |
| March 31, 2007 | -122.19 |
| December 31, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 1.706 |
| Roche Holding AG | -- |
| Oculis Holding AG | -0.2059 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.207M |
| Revenue (Quarterly) | 0.0126M |
| Total Expenses (Quarterly) | 2.22M |
| Enterprise Value | 2.436M |
| Gross Profit Margin (Quarterly) | -153.2% |
| Profit Margin (Quarterly) | -17.52K% |
| Earnings Yield | -277.1% |
| Normalized Earnings Yield | -277.04 |